CERTA Therapeutics
Founded 2018 · 8 employees on LinkedIn · 2 known investors
Find your way into CERTA Therapeutics
Certa Therapeutics develops targeted therapeutics to treat fibrotic diseases including scleroderma, chronic kidney disease, diabetic nephropathy, and focal segmental glomerulosclerosis. The company serves patients with serious, often life-threatening fibrotic conditions.
Investors · 2
Frequently asked questions
- What does CERTA Therapeutics do?
- Certa Therapeutics develops targeted therapeutics to treat fibrotic diseases including scleroderma, chronic kidney disease, diabetic nephropathy, and focal segmental glomerulosclerosis. The company serves patients with serious, often life-threatening fibrotic conditions.
- Who are CERTA Therapeutics's investors?
- CERTA Therapeutics's investors include Stoic VC, UniSeed Pty Ltd..